188 related articles for article (PubMed ID: 23529008)
1. Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.
Tan ML; Dyck BA; Gabriele J; Daya RP; Thomas N; Sookram C; Basu D; Ferro MA; Chong VZ; Mishra RK
Pharmacogenomics J; 2014 Feb; 14(1):63-9. PubMed ID: 23529008
[TBL] [Abstract][Full Text] [Related]
2. Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: examining synapsin II in the pathophysiology of schizophrenia.
Dyck BA; Beyaert MG; Ferro MA; Mishra RK
Schizophr Res; 2011 Aug; 130(1-3):250-9. PubMed ID: 21689907
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotic drugs upregulate synapsin II in the prefrontal cortex of post-mortem samples obtained from patients with schizophrenia.
Guest KA; Dyck BA; Shethwala S; Mishra RK
Schizophr Res; 2010 Jul; 120(1-3):229-31. PubMed ID: 20434888
[No Abstract] [Full Text] [Related]
4. Antipsychotic drug use is correlated with CRP40/mortalin mRNA expression in the dorsolateral prefrontal cortex of human postmortem brain specimens.
Gabriele JP; Pontoriero GF; Thomas N; Ferro MA; Mahadevan G; MacCrimmon DJ; Pristupa ZB; Mishra RK
Schizophr Res; 2010 Jun; 119(1-3):228-31. PubMed ID: 20100649
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: a correlation with BDNF expression.
Pillai A
PLoS One; 2008 Mar; 3(3):e1784. PubMed ID: 18335055
[TBL] [Abstract][Full Text] [Related]
6. Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia.
Porton B; Wetsel WC
Schizophr Res; 2007 Aug; 94(1-3):366-70. PubMed ID: 17540541
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat.
Dyck BA; Tan ML; Daya RP; Basu D; Sookram CD; Thomas N; Mishra RK
Schizophr Res; 2012 May; 137(1-3):32-8. PubMed ID: 22341900
[TBL] [Abstract][Full Text] [Related]
8. Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.
Konopaske GT; Subburaju S; Coyle JT; Benes FM
Schizophr Res; 2015 May; 164(1-3):100-8. PubMed ID: 25757715
[TBL] [Abstract][Full Text] [Related]
9. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
10. Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA.
Basu D; Tian Y; Hui P; Bhandari J; Johnson RL; Mishra RK
Peptides; 2015 Apr; 66():58-62. PubMed ID: 25703303
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression of Synapsin I and II upon Treatment by Lithium and Valproic Acid in Various Brain Regions.
Joshi H; Sharma R; Prashar S; Ho J; Thomson S; Mishra R
Int J Neuropsychopharmacol; 2018 Jun; 21(6):616-622. PubMed ID: 29618019
[TBL] [Abstract][Full Text] [Related]
12. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs.
O'Connor JA; Muly EC; Arnold SE; Hemby SE
Schizophr Res; 2007 Feb; 90(1-3):28-40. PubMed ID: 17141476
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
Mirnics K; Middleton FA; Marquez A; Lewis DA; Levitt P
Neuron; 2000 Oct; 28(1):53-67. PubMed ID: 11086983
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia.
Ohtsuki T; Ichiki R; Toru M; Arinami T
Psychiatry Res; 2000 Apr; 94(1):1-7. PubMed ID: 10788672
[TBL] [Abstract][Full Text] [Related]
15. CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
Kunii Y; Zhang W; Xu Q; Hyde TM; McFadden W; Shin JH; Deep-Soboslay A; Ye T; Li C; Kleinman JE; Wang KH; Lipska BK
Am J Psychiatry; 2015 Nov; 172(11):1122-30. PubMed ID: 26206074
[TBL] [Abstract][Full Text] [Related]
16. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.
Farzan F; Barr MS; Levinson AJ; Chen R; Wong W; Fitzgerald PB; Daskalakis ZJ
Brain; 2010 May; 133(Pt 5):1505-14. PubMed ID: 20350936
[TBL] [Abstract][Full Text] [Related]
17. Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin.
Dean B; Gibbons A; Gogos A; Udawela M; Thomas E; Scarr E
Int J Neuropsychopharmacol; 2018 Mar; 21(3):216-225. PubMed ID: 30052978
[TBL] [Abstract][Full Text] [Related]
18. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.
Albert KA; Hemmings HC; Adamo AI; Potkin SG; Akbarian S; Sandman CA; Cotman CW; Bunney WE; Greengard P
Arch Gen Psychiatry; 2002 Aug; 59(8):705-12. PubMed ID: 12150646
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.
Glausier JR; Enwright JF; Lewis DA
Am J Psychiatry; 2020 Dec; 177(12):1140-1150. PubMed ID: 33115248
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.
Eastwood SL; Harrison PJ
Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
